异动解读|Dianthus Therapeutics Inc.盘前下跌6.74%,高管披露出售1123万美元普通股

行情直击
Nov 16

11月16日,Dianthus Therapeutics Inc.盘前下跌6.74%,报95.0美元/股,成交额1.8万美元。

消息面上,公司执行副总裁、CFO兼CBO Ryan Savitz于11月9日至12日出售124042股普通股,涉及金额约1123万美元。披露显示,这批卖出股份与同期行权获得的124042股相匹配,交易完成后其不再直接持有普通股,但仍保留176884股期权。

此前公司曾表示,截至6月30日现金储备约12亿美元,预计可支持运营至2030年;同时,claseprubart用于gMG的III期EMERGE试验结果预计于下半年公布。此次股价异动更直接对应最新高管减持披露。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10